The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Gr. Regulatory News (JGC)

Share Price Information for Jupiter Gr. (JGC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 181.50
Bid: 180.00
Ask: 183.00
Change: 0.00 (0.00%)
Spread: 3.00 (1.667%)
Open: 181.50
High: 181.50
Low: 181.50
Prev. Close: 181.50
JGC Live PriceLast checked at -
Jupiter Green is an Investment Trust

To achieve capital growth and income, both over the long term, through investment in a diverse portfolio of companies providing environmental solutions.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Jupiter Green Investment Trst (JGC)

14 Mar 2019 15:26

RNS Number : 9319S
Jupiter Green Investment Trust Plc
14 March 2019
 

 

London, UK, 14 March 2019

Edison issues review on Jupiter Green Investment Trust (JGC)

Jupiter Green Investment Trust (JGC) is continuing to benefit from the greater public interest in green issues, which is driving demand growth for companies delivering solutions to environmental challenges. Manager Charlie Thomas and his team run a globally diversified portfolio of c 60 companies, invested across a wide variety of areas, broadly grouped into themes of resource efficiency, demographics and infrastructure. The growing maturity of the investment universe is leading to a larger number of companies paying attractive dividends, enabling JGC to enhance its own dividend policy, with a higher yield (now c 1.3%, from c 0.7%) and semi-annual payouts. As the highest-yielding, closed-ended 'green' equity fund, JGC could see greater demand for its shares, which could help to narrow the currently wider-than-average discount to NAV.

 

JGC's current 5.8% share price discount to cum-income NAV (at 13 March 2019) is wider than the average discounts over one, three and five years, which range from 4.4% to 5.5%. The discount widened from a 0.9% premium in October 2018 as JGC's share price fell amid market volatility, and has remained wider than the medium-term average as the NAV has outperformed the recovering share price. The introduction of a higher, semi-annual dividend may help boost demand for JGC's shares.

Click here to view the full report.

 

SUBSCRIBE TO EDISON'S CONTENT and receive reports emailed directly to you.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Sarah Godfrey, +44 (0)20 3681 2519

Mel Jenner, +44 (0)20 3077 5720

investmenttrusts@edisongroup.com

 

Learn more at Edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAJIMATMBTBBJL
Date   Source Headline
25th Apr 202412:02 pmPRNNet Asset Value(s)
24th Apr 202411:31 amPRNNet Asset Value(s)
23rd Apr 202412:27 pmPRNNet Asset Value(s)
22nd Apr 202412:45 pmPRNNet Asset Value(s)
19th Apr 20245:30 pmRNSTransaction in Own Shares
19th Apr 202411:26 amPRNNet Asset Value(s)
18th Apr 202411:52 amPRNNet Asset Value(s)
17th Apr 202410:58 amPRNNet Asset Value(s)
16th Apr 202411:50 amPRNNet Asset Value(s)
16th Apr 20247:00 amRNSKepler Trust Intelligence: New Research
15th Apr 202411:24 amPRNNet Asset Value(s)
12th Apr 202411:47 amPRNNet Asset Value(s)
11th Apr 202411:42 amPRNNet Asset Value(s)
10th Apr 202411:59 amPRNNet Asset Value(s)
9th Apr 20242:46 pmRNSRejection of Subscription Exercise
9th Apr 202411:53 amPRNNet Asset Value(s)
8th Apr 202412:10 pmPRNNet Asset Value(s)
5th Apr 202411:50 amPRNNet Asset Value(s)
4th Apr 202411:32 amPRNNet Asset Value(s)
3rd Apr 20244:58 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:36 pmPRNNet Asset Value(s)
2nd Apr 20243:37 pmRNSTotal Voting Rights
2nd Apr 202412:50 pmRNSNet Asset Value(s)
28th Mar 202412:09 pmRNSNet Asset Value(s)
27th Mar 202412:09 pmRNSNet Asset Value(s)
26th Mar 202412:09 pmRNSNet Asset Value(s)
25th Mar 202412:09 pmRNSNet Asset Value(s)
22nd Mar 20245:02 pmRNSTransaction in Own Shares
22nd Mar 202412:54 pmRNSNet Asset Value(s)
21st Mar 202412:57 pmRNSNet Asset Value(s)
20th Mar 202412:03 pmRNSNet Asset Value(s)
19th Mar 202411:54 amRNSNet Asset Value(s)
19th Mar 20249:34 amRNSHolding(s) in Company
18th Mar 202411:28 amRNSNet Asset Value(s)
15th Mar 20245:03 pmRNSTransaction in Own Shares
15th Mar 202412:14 pmRNSNet Asset Value(s)
14th Mar 202411:38 amRNSNet Asset Value(s)
13th Mar 202411:59 amRNSNet Asset Value(s)
12th Mar 202412:23 pmRNSNet Asset Value(s)
11th Mar 202412:12 pmRNSNet Asset Value(s)
8th Mar 202412:16 pmRNSNet Asset Value(s)
7th Mar 202411:55 amRNSNet Asset Value(s)
6th Mar 202411:43 amRNSNet Asset Value(s)
5th Mar 202411:45 amRNSNet Asset Value(s)
4th Mar 202412:53 pmRNSNet Asset Value(s)
4th Mar 202410:19 amRNSTransaction in Own Shares- Replacement
1st Mar 20245:05 pmRNSTransaction in Own Shares
1st Mar 20241:20 pmRNSTotal Voting Rights
1st Mar 202412:51 pmRNSNet Asset Value(s)
29th Feb 202411:45 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.